England’s NICE recommends FILSPARI as a treatment option for IgA nephropathy Read More » May 23, 2025
NorthX Biologics Secures Significant Growth Investment from Signet Healthcare Partners Read More » May 20, 2025
FDA Grants Interchangeable Designation to Fresenius Kabi’s biosimilar Otulfi Read More » May 19, 2025
